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We report the identification and characterization of
a five-carbon protein posttranslational modification
(PTM) called lysine glutarylation (Kglu). This protein
modification was detected by immunoblot and mass
spectrometry (MS), and then comprehensively vali-
dated by chemical and biochemical methods. We
demonstrated that the previously annotateddeacety-
lase, sirtuin 5 (SIRT5), is a lysine deglutarylase. Pro-
teome-wide analysis identified 683 Kglu sites in 191
proteins and showed that Kglu is highly enriched on
metabolic enzymes and mitochondrial proteins. We
validated carbamoyl phosphate synthase 1 (CPS1),
the rate-limiting enzyme in urea cycle, as a glutary-
lated protein and demonstrated that CPS1 is targeted
by SIRT5 for deglutarylation. We further showed that
glutarylation suppresses CPS1 enzymatic activity in
cell lines, mice, and a model of glutaric acidemia
type I disease, the last of which has elevated glutaric
acid and glutaryl-CoA. This study expands the land-
scape of lysine acyl modifications and increases our
understanding of the deacylase SIRT5.
INTRODUCTION
Under physiological conditions, cells are constantly exposed
to diverse stressors and variations in energy supply, leading to
fluctuations in cellular energy status. Therefore, cells requireCadaptive strategies to respond to these dynamic changes in
the extracellular environment in order to maintain metabolic ho-
meostasis, including regulation of energy-producing pathways.
Indeed, several mechanisms have been described bywhich cells
adapt to such environmental changes, such as transcriptional
regulation by alterations of epigenetic marks, modulation of
metabolic enzyme activities by cellular metabolites, and protein
posttranslational modifications (PTMs) (Furuya and Uyeda,
1980; Lu and Thompson, 2012). Cellular metabolites play a key
role in the regulation of epigenetic modifications. For example,
acetyl-CoA, SAM, NAD+, and a-ketoglutarate are donors/sub-
strates or cofactors for histone lysine-modifying enzymes, i.e.,
those modulating levels of acetylation and methylation (Imai
et al., 2000; Takahashi et al., 2006; Tsukada et al., 2006; Wellen
et al., 2009). These PTM enzymes have important roles in mod-
ulation of chromatin structure and transcriptional regulation
(Berger, 2007; Chi et al., 2010).
In addition to histones, PTM-regulatory enzymes, such as
AMP-activated protein kinase (AMPK) and lysine deacetylases
(KDACs or HDACs), can control activity of their substrates (Chal-
kiadaki and Guarente, 2012; Hardie et al., 2012), many of which
are metabolic enzymes. Importantly, the activity of these PTM
enzymes can be modified depending on cellular energy status.
For example, sirtuin family HDACs (or class III HDACs) can be
regulated by the cellular NAD+ levels (Imai et al., 2000; Schmidt
et al., 2004). SIRT1 is the homolog to Sir2, the founding member
of this deacetylase subfamily, and has been shown to play an
important role in cellular metabolism (Chalkiadaki and Guarente,
2012). Lysine acetylation levels are coupled to metabolism and
play key roles in regulating mitochondrial enzymes, chromatin
biology, and other cellular processes (Chalkiadaki andGuarente,
2012; Verdin et al., 2010; Xiong and Guan, 2012). Recently, weell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc. 605
Figure 1. Lysine Deglutarylation and Glutaryl-CoA Pathways
(A) Structures of glutaryl-lysine, succinyl-lysine, and malonyl-lysine.
(B) Illustration of glutaryl-CoA synthetic pathways.
Cell Metabolism
Lysine Glutarylation Is a PTM Pathwayidentified lysine succinylation (Ksucc) and malonylation (Kmal) as
protein PTMs (Peng et al., 2011; Xie et al., 2012; Zhang et al.,
2011). We and others showed that SIRT5, a sirtuin family
HDAC, has potent desuccinylase and demalonylase activities
(Du et al., 2011; Peng et al., 2011). A recent study using quanti-
tative proteomics demonstrated that SIRT5 ablation in MEFs in-
duces a dramatic increase of lysine succinylation, demonstrating
that SIRT5 is the major enzyme for lysine desuccinylation in the
cells (Park et al., 2013). In addition, lysine succinylation is an
abundant protein PTM in diverse model organisms (Weinert
et al., 2013). While little is known about the mechanisms of acyl-
ation, succinyl-CoA and malonyl-CoA could serve as the donors
for these two PTM reactions (Du et al., 2011; Peng et al., 2011;
Wagner and Payne, 2013). In addition to these metabolites,
NAD+ is required for SIRT5-dependent desuccinylation and de-
malonylation reactions (Du et al., 2011; Peng et al., 2011).
Together, association of three key cellular metabolites in these
pathways strongly suggests that succinylation and malonylation
PTMs have roles in metabolism (Park et al., 2013). It remains un-
known if additional PTMs exist that could control cellular meta-
bolic circuits.
In this study, we report a type of lysine modification called
lysine glutarylation (Kglu). First, we identified and comprehen-
sively validated Kglu as an evolutionarily conserved PTM. We
then showed that SIRT5 catalyzes lysine deglutarylation both
in vitro and in vivo. We further validated CPS1, the rate-limiting
enzyme important for ammonia detoxification in urea cycle, as
a glutarylated substrate. Glutarylation of CPS1 inhibits its activity
but can be reversed by SIRT5. We further showed that in a glu-
taric acidemia type I (glutaryl-CoA dehydrogenase deficiency)
disease model of elevated glutaryl-CoA, mice have elevated
glutarylation of mitochondrial proteins, including CPS1, and606 Cell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc.reduced CPS1 enzymatic activity, suggesting protein glutaryla-
tion as one possible alternative fate of elevated glutaryl-CoA
in this disease. We demonstrate that Kglu is a SIRT5- and
nutrient-regulated PTM, which impacts metabolic processes
and other mitochondrial functions.
RESULTS
We recently described two acyl modifications, lysine succinyla-
tion and malonylation (Peng et al., 2011; Xie et al., 2012; Zhang
et al., 2011). Succinyl-CoA and malonyl-CoA can be cofactors
for lysine succinylation and lysine malonylation, respectively
(Du et al., 2011; Peng et al., 2011;Wagner and Payne, 2013). Glu-
taryl-CoA is structurally similar to succinyl-CoA and malonyl-
CoA (Figure 1A) and is an important metabolite of amino acid
metabolism (Figure 1B and see Figure S1 available online). We
predicted that glutaryl-CoA could serve as the donor molecule
for the Kglu reaction (Koeppen et al., 1979; Mitzen and Koeppen,
1984), analogous to a role for acetyl-CoA in lysine acetylation.
Indeed, we have shown that a few other short-chain acyl-CoAs
can serve as precursors of lysine acylation, such as lysine pro-
pionylation, lysine butyrylation, and lysine crotonylation (Chen
et al., 2007; Tan et al., 2011).
To test whether Kglu could be detected in vivo, we generated a
pan-anti-Kglu antibody. This anti-Kglu antibody detected its anti-
gen peptide bearing a fixed glutarylated lysine (Kglu), but not pep-
tide libraries bearing a fixed unmodified lysine (K), acetyl-lysine
(Kac), malonyl-lysine (Kmal), or succinyl-lysine (Ksucc) (Figure 2A).
This result demonstrated high specificity of the antibody for
lysine-glutarylated peptides.
To examine whether Kglu is evolutionarily conserved, we per-
formed immunoblot analysis using the anti-Kglu antibody with
whole-cell lysates from different species: E. coli, S. cerevisiae,
Drosophila melanogaster (S2), mouse (MEFs), and human cells
(HeLa). Multiple bands were detected in all species, and these
signals could be efficiently competed away by the tryptic pep-
tides of glutarylated bovine serum albumin (BSA), but not the
corresponding tryptic peptides of unmodified BSA (Figures 2B
and S2A). These results suggest that Kglu is a broadly conserved
PTM and is present in both eukaryotic and prokaryotic cells.
Identification of E. coli and Human Kglu Substrates
To identify potential Kglu substrates in E. coli and HeLa cells, we
used an affinity enrichment-based proteomics approach as pre-
viously described (Chen et al., 2012; Kim et al., 2006). Glutary-
lated peptides were first enriched using the pan-anti-Kglu
antibody from tryptic digest of E. coli, and then analyzed by
HPLC-mass spectrometry (MS)/MS. The acquired MS/MS
spectra were analyzed by Mascot software to identify potential
Kglu peptides. We used strict manual verification criteria to filter
out false positives, as previously described (Chen et al., 2005),
to ensure bona fide identification of glutarylated lysines (Table
S1). In this pilot experiment, we detected 23 and 10 Kglu peptides
from E. coli and HeLa cells, respectively.
Verification of Kglu Using Synthetic Peptides
Because lysine-glutarylated peptides have not been described
in the past and affinity enrichment of Kglu peptides may identify
some structural isomers, it is therefore important to confirm the
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dem mass spectrometry) and HPLC coelution experiments for
the in vivo-derived peptides and their synthetic counterparts.
Peptides with identical primary sequences and modifications
at the same residues should exhibit the same HPLC retention
times and MS/MS fragmentation patterns. Therefore, compara-
tive analysis of in vivo-derived peptides bearing the PTM of inter-
est with their corresponding synthetic standards is an ideal
approach to validate a PTM. We chemically synthesized two
Kglu peptides, SKgluATNLLYTR and NFSTVDIQKgluNGVK, based
on Kglu peptide candidates originally identified from E. coli and
HeLa cell, respectively. We performed MS/MS and HPLC coelu-
tion experiments to verify the chemical identity of the in vivo-
derived peptides. The MS/MS spectrum of a tryptic peptide
from E. coli DNA protection during starvation protein
(SK+114.0281DaATNLLYTR) with a mass shift of +114.0281Da at
the lysine residue has the same MS/MS spectrum as that of
the synthetic peptide with a glutaryl group on lysine residue
(SKgluATNLLYTR) (Figure 2C). In addition, the in vivo-derived
peptide coeluted with the synthetic one by the reverse-phase
HPLC/MS analysis (Figure 2D), further confirming that the de-
tected mass shift of + 114.0281Da in the in vivo-derived peptide
is caused by Kglu. Similarly, we also confirmed Kglu in a tryptic
peptide of the DNA mismatch repair protein Msh2 from HeLa
cells, NFSTVDIQK+114.0311DaNGVK (Figures S2B and S2C).
Validation of Kglu by Isotopic D4-Glutarate Labeling
Isotopic labeling is a method of choice to investigate the origin of
the carbon backbones of PTMs. Succinate and malonate can be
used by cells to generate lysine succinylation and malonylation,
respectively, presumably by generating succinyl-CoA and ma-
lonyl-CoA intermediary metabolites (Peng et al., 2011; Zhang
et al., 2011). Therefore, we hypothesized that Kglu may also be
labeled with isotopically labeled glutarate via the in vivo conver-
sion of D4-glutarate to D4-glutaryl-CoA. To test this hypothesis,
we first treated HeLa cells with nonisotopic glutarate. Our result
showed that glutarate can slightly enhance levels of global
glutarylation but has no influence on lysine acetylation and suc-
cinylation (Figure S2D). We then treated the cells with 20 mM
isotopically labeled D4-glutarate for 24 hr. Proteins’ whole-cell
lysates were isolated and digested with trypsin. Kglu peptides
were enriched by immunoprecipitation using the anti-Kglu anti-
body and analyzed by HPLC-MS/MS for peptide identification.
Isotopically (D4) labeled Kglu peptides (with an additional +4 Da
mass shift) can be distinguished from the regular Kglu on the
MS spectrum. This analysis revealed that the Kglu peptide iden-
tified from HeLa cells, NFSTVDIQKgluNGVK, was indeed labeled
with D4-glutarate (Figure S2E). These results further confirmed
the structure of this modification, and identified glutarate as
one metabolite that can be a precursor to Kglu. Together, four in-
dependent approaches, western blotting analysis, MS/MS and
HPLC coelution with synthetic peptides, and isotopic labeling,
identified and validated Kglu as a PTM and its presence in spe-
cies ranging from bacteria to mammals.
Screening of HDAC Lysine Deglutarylation Activity
In Vitro
Based on the structural similarity between lysine malonylation
and lysine succinylation (Figure 1A), we hypothesized Kglu couldCbe removed by SIRT5. To test this hypothesis, we first used a
fluorescence-based assay to screen all HDACs (including
HDAC 1–11 and sirtuin 1–7) for lysine deglutarylation activity,
as described previously (Peng et al., 2011) and as illustrated in
Figure S3A. Using this assay, we found SIRT5 is the only
HDAC exhibiting significant lysine deglutarylase activity in vitro
(Figures 3A and S3B).
In a second fluorescence-independent assay, we further
tested the ability of the sirtuins to deglutarylate peptide or protein
substrates. We used an assay that monitors the consumption
of 32P radio-labeled NAD+ by the sirtuins using two different sub-
strates. First, acylated histone 4 (H4) peptide was generated
enzymatically by incubating a peptide derived from H4 1–21
with recombinant p300 in the presence of acetyl-CoA, succi-
nyl-CoA, or glutaryl-CoA. We observed NAD+ hydrolysis,
coupled with the generation of O-acyl-ADP-ribose (OA-ADPR),
indicating sirtuin catalyzed deacylation (Figure S3C). As ex-
pected, SIRT3 effectively deacetylated the acetylated peptide
and SIRT5 effectively desuccinylated the succinylated peptide
(Figure S3C). SIRT5 also deglutarylated the glutarylated pep-
tide (Figure S3C). SIRT4 showed no activity against any of these
modifications (Figure S3C). To test a more physiological and
more complex substrate in this assay, we chemically acylated
BSA. Similar to the previous assay, we found SIRT3 deacety-
lated the acetyl-BSA substrate, while SIRT5 desuccinylated
and deglutarylated these acylated BSA substrates (Figure 3B).
These data further confirmed the deglutarylase activity for
SIRT5.
The fluorescent sirtuin deacylation assay and other assays
using pseudosubstrates have presented challenges to the sirtuin
field. Questions about the ability of sirtuins to faithfully deacylate
native peptides are often raised. Therefore, we performed a third
enzymatic activity assay on known SIRT5-targeted peptides. We
carried out an in vitro lysine deglutarylation reaction using the
synthetic Kglu peptide, VKSKgluATNLWW, whose sequence is
from DNA starvation/stationary phase protection (Dps) protein
identified in our proteomic data described above. We used
HPLC-MS to evaluate SIRT5-mediated lysine deglutarylation.
Our data showed that SIRT5 could catalyze efficient lysine de-
glutarylation (Figures 3C and S3D–S3G). The reaction required
NAD+ as cofactor and could be inhibited by nicotinamide
(NAM) (a class III HDAC inhibitor); however, the reaction could
not be inhibited using other HDAC inhibitors including trichosta-
tin A (TSA), sodium butyrate (NaBu) (class I/II/IV HDAC inhibitors)
or sirtinol (a selective SIRT1 and SIRT2 inhibitor) (Figure 3C).
Additionally, the enzymatically inactive mutant of SIRT5
(H158Y) showed no lysine deglutarylase activity (Figure 3C).
Further, SIRT5 is only one of the 18 recombinant HDACs that
showed significant deglutarylation activity (Figure S3G). These
results demonstrate that SIRT5 can catalyze NAD+-dependent
lysine deglutarylation using peptides with sites of glutarylation
we identified in vivo.
Kinetic Studies on SIRT5 Deglutarylase Activity
To define the kinetics of the deglutarylase reaction of SIRT5, we
returned to the fluorescent substrates, which can be used to
quantify the amount of deglutarylation over time. We first tested
for its ability to process lysine side chains derivatized with dicar-
boxylic acids of varying lengths ranging from three to six carbonell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc. 607
Figure 2. Detection and Verification of Lysine Glutarylation
(A) Specificity of the anti-Kglu antibody. Dot blot assay was carried out using anti-Kglu antibody by incubation of the peptide libraries bearing a fixed unmodified K,
Kac, Kmal, Ksucc, and Kglu, respectively. Each peptide library contains 10 residues, CXXXXKXXXX, where X is a mixture of 19 amino acids (excluding cysteine), C is
(legend continued on next page)
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adipoyllysine). Two series of fluorogenic peptide substrates con-
taining 7-amino-4-methylcoumarin (AMC) were evaluated: one
series based on a simple a-N-acetylated lysine (Figure 4A) and
one containing the tripeptide sequence, Ac-Leu-Gly-Lys(acyl),
which is based on H4K12—a common substrate for deacylation
(Bradner et al., 2010) (Figure S4A). Similar results were obtained
for both series with high potencies of both human and murine
SIRT5 recorded against succinylated and glutarylated sub-
strates, while activities were lower against malonylated sub-
strates (1.3-fold relative to control wells without sirtuin), and
the enzymes exhibited no measurable deacetylase or deadipoy-
lase activity. We furthermore included an inactive histidine to
tyrosine mutant of the human SIRT5, which expectedly exhibited
low activity (Figure 4A). To compare the enzymatic efficiencies
against different acyl groups, we then performed detailed kinetic
studies using the tripeptide substrates containing malonyl-
lysine (Kmal), succinyl-lysine (Ksucc), and glutaryl-lysine (Kglu) by
measuring initial rate velocities as a function of substrate con-
centration and fitting the data to the Michaelis-Menten equation
as previously described (Madsen and Olsen, 2012) (Figure S4B;
Table S2A). The turnover numbers (kcat) and catalytic efficiencies
(kcat 3 Km
1) were significantly higher for desuccinylation and
deglutarylation compared to the demalonylase activity, in agree-
ment with our endpoint data, and desuccinylase activity ap-
peared 2-fold more efficient than deglutarylase activity, albeit
at lower Km values for the glutarylated substrate.
To determine if the deglutarylase activity of SIRT5 was depen-
dent on the peptide sequence of the substrate, we measured
differences in lysine deacetylation, desuccinylation, and deglu-
tarylation activities of SIRT5 using two peptide sequences we
identified in our proteomics screen (Table S2B). For both of these
two peptide substrates, the catalytic efficiencies for deglutaryla-
tion and desuccinylation were comparable, and significantly
higher than that for deacetylation (Table S2B), which is in agree-
ment with previous reports (Du et al., 2011; Peng et al., 2011).
Together, these experiments demonstrate the major activity of
SIRT5 is to remove lysine malonylation, succinylation, and gluta-
rylation, but not acetylation.
To better understand how SIRT5 can catalyze these deacyla-
tion reactions, we performed in silico molecular modeling and
simulation experiments to compare the binding interaction be-
tween SIRT5 and various acylated peptide substrates (Figures
4B, 4C, S4C–S4E; Table S2C; detailed analyses are included in
the Supplemental Experimental Procedures). The predicted
energy of the interaction was essentially identical between the
malonyl-, succinyl-, or glutaryl-modified histone peptides and
SIRT5, but was substantially less favorable involving either the
acetyl or the adipoyl modifications (Figure 4C). Differences in
interaction energy were almost entirely due to changes in pre-cysteine, and the sixth residue is a fixed lysine residue: unmodified lysine (K),
lysine (Kglu).
(B) Western blot of the whole-cell lysates from bacteria E. coli, yeast S. cerev
performed using the whole-cell lysates from different cells.
(C) High-resolution MS/MS spectra of an E. coli tryptic peptide (SK+114.0281DaATN
shift of +114.0281 Da at the lysine residue (bottom) and the synthetic SKgluATNL
(D) Extracted ion chromatograms (XICs) of the synthetic peptide SKgluATNLLY
(bottom) by reverse-phase HPLC analysis.
Cdicted electrostatic interactions (Figure 4C). These results sup-
port our enzymatic activity data and demonstrate how glutaryl
groups can be preferably removed by SIRT5, in a similar manner
as lysine succinylation and malonylation, but not acetylation or
adipoylation.
SIRT5 Can Catalyze Protein Lysine Deglutarylation
In Vivo
To validate the results of the in vitro studies, we examined Kglu
and lysine succinylation in Sirt5+/+ (WT) and Sirt5/ (KO) mouse
tissues. Usingmitochondrial protein lysates from tissues derived
from WT and KO mice, we found that SIRT5 has a significant
impact on the global Kglu state (Figures 5A and S5A–S5D). In
contrast, SIRT5 has little influence on global lysine acetylation
(Lombard et al., 2007). These experiments suggest that SIRT5
regulates the global mitochondrial Kglu status. Taken together,
these biochemical studies reveal that SIRT5 is the only HDAC
capable of acting as a lysine deglutarylase, both in vitro and
in vivo. These findings also position SIRT5 to efficiently remove
carboxyacyl-modifications including malonyl-lysine, succinyl-
lysine, and now glutaryl-lysine.
Proteome-wide Screening of Kglu Substrates in Sirt5
–/–
Mouse Liver
To characterize the landscape of Kglu, we performed proteomic
screening using livers from Sirt5/mice, which showed marked
protein hyperglutarylation (Figures 5A and S5A). Using the glu-
taryl-peptide enrichment and MS strategy described above,
we identified 911 Kglu sites on 229 proteins with less than 1%
false discovery rate (FDR) using MaxQuant software. In addition,
we further filtered out those Kglu peptides with Mascot ion score
lower than 20 to increase the reliability of the results. Based on
these stringent criteria, 683 lysine sites in 191 proteins were
identified as glutarylated and used for further bioinformatics an-
alyses (Table S3). While approximately half of the Kglu proteins
contained only one or two Kglu sites (Figure 5B), some proteins
were heavily glutarylated, including carbamoyl-phosphate syn-
thetase 1 (CPS1, 33 Kglu sites), long-chain enoyl-CoA hydratase
(HADHA, 15 Kglu sites), and aspartate aminotransferase (GOT2,
14 Kglu sites) (Table S3). We realized that some Kglu sites overlap
with those Kac and Ksucc sites published previously (Chen et al.,
2012; Du et al., 2011; Park et al., 2013).
Bioinformatic Analyses of Kglu Substrates
To identify the possible association of Kglu substrates with
cellular functions, we carried out gene ontology (GO) enrichment
analysis using DAVID bioinformatics resources (Huang et al.,
2009). The results of GO biological process analysis showed
that Kglu was significantly enriched in many cellular metabolic
processes, including oxidation reduction (p = 2.6 3 1039),acetyl-lysine (Kac), malonyl-lysine (Kmal), succinyl-lysine (Ksucc), and glutaryl-
isiae, Drosophila S2, mouse MEF, and human HeLa cells. Western blot was
LLYTR) from DNA starvation/stationary phase protection protein with a mass
LYTR (top). Inset shows the mass-to-charge ratios (m/z) of the precursor ions.
TR (top), the in vivo-derived peptide (middle, from E. coli), and their mixture
ell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc. 609
Figure 3. SIRT5 Catalyzes Lysine Deglutarylation Reactions In Vitro
and In Vivo
(A) Screening of HDAC lysine deglutarylation activity in vitro. Fluorometric
assay to detect in vitro lysine deglutarylation activities using recombinant
SIRT1-7.
(B) 32P-NAD+ consumption monitored by thin-layer chromatography after an
in vitro SIRT3, SIRT4, or SIRT5 enzymatic assay using chemically acylated
BSA as a substrate; o-glutaryl-ADP ribose, OG-ADPR; o-succinyl-ADP ribose,
OS-ADPR; o-acetyl-ADP ribose, OA-ADPR.
(C) HPLC trace of a glutarylated peptide, VKSKgluATNLWW, before and after
in vitro deglutarylation reaction. The assays were carried out without hSIRT5,
with hSIRT5, with enzymatically inactive mutant of hSIRT5 (H158Y), without
NAD+, with SIRT5 in the presence of nicotinamide (25 mM), sirtinol (200 mM),
TSA (2 mM), or sodium butyrate (NaBu) (25 mM). A triangle and a diamond
indicate modified (HRMS, m/z, 673.8588 Da) and unmodified (HRMS, m/z,
616.8439 Da) peptides, respectively.
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1027), fatty acid metabolism (p = 5.03 1020), coenzyme meta-
bolism (p = 8.43 1018), and aerobic respiration (p = 1.23 1013)
(Figure 5C; Table S4A). The enriched GO molecular functions
(GOMFs) are associated with various cofactor binding pro-
cesses, such as coenzyme (p = 8.6 3 1021), FAD (p = 1.8 3
1011), and vitamin (p = 2.2 3 109) binding, as well as oxida-
tion-reduction-related functions, including acyl-CoA dehydroge-
nase activity (p = 8.1 3 1012), NAD+/NADP+-related aldehyde/
oxo group oxidoreductase activity (p = 3.13 109), and electron
carrier activity (p = 3.6 3 108) (Figure S5E; Table S4B). These
data reveal that protein glutarylation could be involved in regu-
lating diverse cellular mechanisms and enzymatic processes.
GO cellular compartment (GOCC) analysis showed that Kglu pro-
teins were highly enriched in mitochondria (Figure S5F; Table
S4C). Strikingly, 148 Kglu proteins in mouse liver were mainly or
partially localized to mitochondria, accounting for more than
three-quarters of all identified lysine-glutarylated proteins in
this study. Taken together, these lines of evidence suggest a
strong link between Kglu and mitochondrial metabolism. Sub-
sequent KEGG and Pfam enrichment analyses suggested a
potential impact of protein glutarylation on metabolic pathways
(Figures S5G–S5L; Tables S4D and S4E) involving glutaryl-CoA
and oxidative metabolism. In addition, we also carried out
analysis of protein complexes and interaction networks, using
CORUM and STRING databases, identifying protein complexes
whose components are enriched with Kglu (Figures S5M–S5O;
Tables S4F and S4G; analyses are included in the Supplemental
Experimental Procedures).
SIRT5Deglutarylates CPS1 and Regulates Its Enzymatic
Activity
To begin to identify the physiological consequence of protein
glutarylation, we looked to the proteins with the highest number
of glutarylation sites in SIRT5KO mouse livers. We found CPS1,
33 sites; HADHA, 15; GOT2, 14; MDH2, 13; SDHA, 13; ACAA2,
11; ACAT1, 11; HADH, 11; SCP2, 11; and OTC, 10 (Table S3).
Because CPS1 was the protein identified with the highest level
of glutarylation, and SIRT5 has been previously described to
regulate CPS1 (Nakagawa et al., 2009), we sought to determine
if glutarylation had a functional effect on CPS1 enzymatic activity
and was regulated by SIRT5. We found CPS1 was hyperglutary-
lated in SIRT5KO mice during fed and fasted (48 hr) conditions,
consistent with our proteomic findings above (Figure 6A).
Figure 4. Enzymology Studies on SIRT5-Catalyzed Deglutarylation
(A) Endpoint deacylation assay of mouse or human wild-type SIRT5 or human
mutant SIRT5 (HY mutant) against acylated monolysine-AMC substrates; Kac,
acetyl; Kmal, malonyl; Ksucc, succinyl; Kglu, glutaryl; Kadi, adipoyl. Error bars in
this figure and subsequent ones represent standard error of the mean (SEM).
(B) Crystal structure of SIRT5 with a glutarylated peptide superimposed in the
catalytic pocket.
(C) Summary of total interaction energy comprising the sum of Van der Waals
and electrostatic interaction energies between SIRT5 and acylated histone
peptides (shown in Figure S4D).
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CHyperglutarylation was associated with reduced hepatic CPS1
enzymatic activity in SIRT5KO mouse liver (Figure 6B), which
leads to an increase in blood ammonia levels (Nakagawa et al.,
2009).
Because we observed basal levels of protein glutarylation in
HeLa cells, we generated stable cells lines containing SIRT5 or
Scramble (Scr) control shRNAs (Figure S6A). HeLa cells contain
high levels of CPS1 protein (EMBL-EBI, http://www.ebi.ac.uk).
Thus we attempted to immunoprecipitate endogenous CPS1
from both shSIRT5 and shScr control cell lines to determine its
level of protein glutarylation. We observed CPS1 hyperglutaryla-
tion after SIRT5 knockdown compared to control (Figure 6C).
Interestingly, we observed toxicity in the shSIRT5 cell culture
model upon prolonged time in culture media, suggesting the
shSIRT5 cells could be producing a toxic metabolite. We
measured ammonia in this model after 24 hr of serum starvation,
and observed significant increases in ammonia in the cell culture
media (Figure 6D), consisted with CPS1 protein hyperglutaryla-
tion and reduced CPS1 enzymatic activity. Furthermore, we
observed increased ornithine in shSIRT5 HeLa cells, supporting
reduced urea/ornithine cycle flux (Figure 6E).
To further test the role of SIRT5 in deglutarylating and regu-
lating CPS1, we generated a HEK293T containing a stable
shSIRT5 or shScramble control, which do not contain endoge-
nous CPS1. Cell lines containing the shSIRT5 had increased
global protein glutarylation, but only modest increases in protein
succinylation (Figure S6B). CPS1 was overexpressed in shSIRT5
and scramble control cells, and found to be hyperglutarylated
(Figure 6F). Because the increases in glutarylation in these
models were only associated with reduced SIRT5, we tested
for the ability of SIRT5 to directly deglutarylate CPS1. To do
so, we overexpressed recombinant CPS1 protein in HEK293T
cells and chemically glutarylated this protein using glutaric anhy-
dride. We then incubated glutarylated CPS1 with wild-type
SIRT5, or a catalytically inactive SIRT5H158Y (SIRT5HY) mutant.
We observed significant deglutarylation of CPS1 by SIRT5, but
not SIRT5HY, supporting the idea that SIRT5 deglutarylates
CPS1 and the absence of SIRT5 directly leads to elevated pro-
tein glutarylation (Figure 6G).
To gain insight into which Kglu sites could be targeted by SIRT5
for removal, we chemically glutarylated CPS1 and then per-
formed an in vitro SIRT5 deglutarylation assay. We then sub-
jected these preparations to HPLC-MS/MS analysis. We used
this strategy based on the rationale that chemical glutarylation
would lead to nearly complete coverage of lysine residues with
the glutaryl modification, and SIRT5 would deglutarylate only
specific sites, leading to a comprehensive map of deglutarylated
lysines. We found 44 sites of glutarylation on chemically treated
recombinant CPS1, and 31 sites of glutarylation after incubationell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc. 611
Figure 5. Proteomic and Bioinformatic Analyses of Kglu Substrates
in WT and SIRT5KO Mouse Liver
(A) Western blotting analysis of mitochondria from Sirt5+/+ (WT) and Sirt5/
(KO) mouse livers.
(B) Distribution of Kglu sites per protein identified by proteomic analysis.
(C) Gene ontology (GO) of biological processes (BP) of proteins identified as
glutarylated by proteomics.
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modified to unmodified CPS1 peptides after SIRT5 treatment,
we identified 14 candidate lysine residues that could be effi-
ciently deglutarylated by SIRT5 (Table S5). Finally, we compared
these 14 sites to glutarylated lysines found in SIRT5KO liver, to
ensure that these sites are found in a physiological setting and
not an artifact of chemical acylation. In sum, we identified eight
candidate Kglu sites on CPS1 that are targeted for removal
by SIRT5 (K55, K219, K412, K889, K892, K915, K1360, and
K1486; Table S5).
To begin to determine how glutarylation suppresses CPS1
enzymatic activity, we performed a structural analysis on CPS1
protein and identified where these eight Kglu sites were located.
A human CPS1 crystal structure has not been solved, and there-
fore we built a homology model of CPS1 with the MODELER pro-
tocol (Eswar et al., 2008) using the crystal structure of E. coli
carbamoylphosphate synthetase (Thodenetal., 1999) (Figure6H).
On this homology model, we visualized the sites of glutaryla-
tion, in order to determine the possible mechanism(s) of regula-
tion by SIRT5. K55, K219, and K412 are in or nearby the inactive
glutamine amidotransferase domain in the a subunit of CPS1612 Cell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc.(Figure 6H, green). This region has been predicted to be impor-
tant for CPS1 structure (Lopes-Marques et al., 2012); alterna-
tively, these sites could be important for CPS1-interacting
proteins, such as with glutaminase (Meijer, 1985). K889, K892,
and K915 are all located in the CPS1 oligomerization domain,
based on homology to E. coli carB (Figure 6H, blue). CPS1 is pre-
sent as a homodimer and is active in its monomeric form
(Gutho¨hrlein and Knappe, 1968). Glutarylation of these sites
could disrupt the regulation of CPS1 by oligomerization. K1360
andK1486both lie in the region of allosteric activation (Figure 6H,
magenta). CPS1 requires N-acetylglutamate (NAG) as an obli-
gate allosteric activator (Hall et al., 1958). Glutarylation of these
sites could influence the activation of CPS1 by NAG, which could
be reversed by SIRT5. Together, a picture emerges for SIRT5 to
regulate CPS1 function by several possible mechanisms.
Protein Hyperglutarylation Is Sensitive to Dietary
Changes
To further explore the physiological role of glutarylation, we
considered possible metabolic states that might lead to altered
protein glutarylation. Wemonitored changes in protein glutaryla-
tion of whole-cell lysate from WT and SIRT5KO mouse liver dur-
ing feeding and fasting (48 hr). Similar to protein succinylation,
protein glutarylation changes in response to dietarymanipulation
(Figures 7A and S7A). We observed, in WT mouse livers, some
bands were increased with fasting, while other bands were
reduced, suggesting SIRT5 could be regulating these sites (Fig-
ures 7A and S7A). Importantly, the banding pattern of protein
glutarylation was different than the patterns of succinylation,
suggesting that different proteins are subject to regulation by
different chemical modifications. We also measured changes
in acyl-CoA concentrations during a fasting time course in whole
mouse liver. We found that fasting induces different changes in
succinyl- and glutaryl-CoA concentrations (Figure S7B), further
supporting different mechanisms of regulation for different
acyl-CoA species.
To determine if other dietary manipulations lead to changes in
protein glutarylation, we performed a tryptophan supplementa-
tion experiment. As described above, tryptophan degradation
leads to glutaryl-CoA, and therefore we predicted that increased
tryptophan would lead to increased protein glutarylation.
Drosophila were fed with 0X, 1X, or 2X tryptophan for 1 week,
and whole-cell lysates were measured for protein glutarylation
by western blot. We observed increases in protein glutarylation
(Figures 7B and S7C), consistent with the idea that excess tryp-
tophan is degraded and generates increased glutaryl-CoA,
which can lead to increased protein glutarylation.
Protein Hyperglutarylation in a Mouse Model of Human
Glutaric Acidemia
We also considered pathophysiological states which might be
associated with altered protein glutarylation. Glutaric Acidemia
I (GA, OMIM 231670) is an autosomal recessive metabolic disor-
der in humans characterized by a progressive movement disor-
der that usually begins during the first year of life. GA is caused
by homozygous or compound heterozygous mutations in the
gene encoding glutaryl-CoA dehydrogenase (GCDH). Because
GCDH catalyzes the oxidative decarboxylation of glutaryl-CoA
into crotonyl-CoA in the lysine and tryptophan degradation
Figure 6. Carbamoyl Phosphate Synthase 1 Is Targeted for Deglu-
tarylation by SIRT5
(A) CPS1 was immunoprecipitated from SIRT5 WT and KO mouse liver under
fed and 48 hr fasted conditions and measured for glutarylation levels using an
anti-Kglu antibody.
(B) CPS1 enzymatic activity was measured in hepatic lysates in SIRT5 WT and
KO mice, and presented relative to WT control mice. Error bars represent
standard error of the mean (SEM).
(C) CPS1 was immunoprecipitated from HeLa cells containing a shScramble
(SCR) or shSIRT5 and measured for glutarylation levels using an anti-Kglu
antibody.
(D) Ammonia levels fromHeLa cells containing a shScramble (SCR) or shSIRT5
after 24 hr of serum starvation. Error bars represent SEM.
(E) Ornithine levels from HeLa cells containing a shScramble (SCR) or shSIRT5
after 24 hr of serum starvation. Error bars represent SEM.
(F) CPS1 was transfected in HEK293 cells containing a shScramble (SCR) or
shSIRT5, immunoprecipitated, and measured for glutarylation levels using an
anti-Kglu antibody.
(G) CPS1 was transfected in HEK293 cells and immunopurified. Glutarylation
levels were measured using an anti-Kglu antibody in four samples: CPS1,
glutarylated CPS1 that was chemically modified with glutaric anhydride (GA),
glutarylated CPS1 after incubation with recombinant human SIRT5, and glu-
tarylated CPS1 after incubation with recombinant human SIRT5 HY mutant.
(H) A homology model of human CPS1 was built based on an E. coli CarA
homologous region (light gray), encompassing an inactive glutamine amido-
transferase domain (teal), and an E. coli CarB homologous region (dark gray)
containing two ATP grasp domains (cyan), an oligomerization domain (blue),
and a NAG-binding site (magenta). Glutarylated lysine residues targeted for
SIRT5 removal are labeled and highlighted in yellow.
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Cpathways, and GA patients as well as GCDHKO mice display
increased levels of glutaryl-CoA (Goodman and Frerman, 2001;
Koeller et al., 2002), we predicted loss of GCDH would result
in increased protein glutarylation. We purified hepatic mito-
chondria from wild-type and Gcdh/ (GCDHKO) mice, and
measured the state of protein acylation. Remarkably, we
observed increased dramatic global protein glutarylation (Fig-
ure 7C). We also tested for succinylation and saw no protein hy-
persuccinylation in the GCDHKO hepatic mitochondrial protein
lysates (Figure 7C), demonstrating that the elevation of protein
glutarylation is specific in this mouse model. Together, these
data suggest that low GCDH activity could lead to elevated pro-
tein glutarylation.
To determine if protein glutarylation has a functional conse-
quence in this mouse model, we assessed the glutarylation
state of CPS1. We immunopurified CPS1 from wild-type and
GCDHKO mice and found that CPS1 was hyperglutarylated in
GCDHKO mouse liver (Figure 7D). We then measured CPS1
enzymatic activity in this model and found hyperglutarylated
CPS1 in GCDHKO mice was less active compared to wild-type
(Figure 7E). Remarkably, GCDHKO mice express more CPS1
protein compared to wild-type (Figure S7D), presumably to over-
come the reduction in protein activity and maintain nitrogen bal-
ance (Thies, 2010). These data suggest that one alternative fate
of increased glutaryl-CoA in the absence of GCDH is protein
glutarylation. To test if glutaryl-CoA could directly lead to nonen-
zymatic protein glutarylation, we incubated heat-inactivated
mitochondrial protein lysates with 50–500 mM glutaryl-CoA. We
observed increases in protein glutarylation with increasing glu-
taryl-CoA concentrations (Figures 7F and S7E), suggesting that
glutaryl-CoA can lead to this protein modification, similar to
acetyl-CoA, crotonyl-CoA, and succinyl-CoA (Tan et al., 2011;ell Metabolism 19, 605–617, April 1, 2014 ª2014 Elsevier Inc. 613
Figure 7. Physiology and Pathophysiology of Lysine Glutarylation
(A) Protein glutarylation was measured in hepatic whole-tissue lysates
by immunoblotting with an anti-Kglu antibody in two sets (mouse 1 and
mouse 2) of SIRT5 WT and KO mice that were fed or fasted (48 hr),
respectively.
(B) Drosophiliawere fed with 03, 13, or 23 tryptophan for 1 week, and whole-
cell lysates were prepared for western blotting analysis.
(C) Hepatic mitochondrial protein glutarylation and succinylation were
measured by immunoblotting with anti-acyl-lysine antibodies in WT and glu-
taryl-CoA dehydrogenase knockout (GCDHKO) mice.
(D) CPS1 was immunoprecipitated from GCDHKO mouse liver and measured
for glutarylation levels using an anti-Kglu antibody.
(E) CPS1 enzymatic activity was measured in hepatic lysates from wild-type
and GCDHKO mice and normalized to total CPS1 protein levels. Error bars
represent SEM.
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serum albumin (BSA) can also be nonenzymatically glutary-
lated with glutaryl-CoA (Figure S7F). Importantly, this was not
observed using glutarate as a substrate for acylation (Figure 7F),
which demonstrates the requirement for reactive thioesters in
this pathway.
DISCUSSION
In this study, we identified Kglu as an evolutionally conserved
PTM, which is regulated by SIRT5 in a NAD+-dependent manner.
SIRT5was originally annotated as a deacetylase (Frye, 2000) and
was predicted to have deacetylase activity, but appears to pref-
erentially deacylate negatively charged modifications, including
malonylation, succinylation, and glutarylation. The enzymatic
activity assays, substrate docking studies, and energyminimiza-
tions all indicate that the SIRT5 catalytic pocket can accommo-
date these carboxyacyl-lysines for optimal enzymatic activity.
Together, these findings support the idea that SIRT5 is not a
physiological deacetylase, and instead removes a class of car-
boxyacyl-lysine modifications.
Our proteomic analyses of Kglu in SIRT5KO mouse liver led to
the identification of 683 Kglu sites on 191 proteins. Interestingly,
over three-quarters of the Kglu substrates were mitochondrial.
Because SIRT5 plays an important role in the mitochondria
(Nakagawa et al., 2009; Park et al., 2013), Kglu appears to play
a major role in this organelle. Our bioinformatic analyses showed
that Kglu is highly enriched with metabolic processes, such as
cellular respiration, and fatty acid and amino acid metabolism,
similar to what has been observed for acetylation and succinyla-
tion (Chen et al., 2012; Hebert et al., 2013; Park et al., 2013).
As a first step toward understanding the physiological role of
glutarylation, we turned to the list of proteins with the highest
levels of glutarylation. Not surprisingly, CPS1 was at the top of
the list, which is also heavily succinylated and acetylated. Just
like these other modifications, not all Kglu sites are candidates
for deacylation. On CPS1, eight Kglu sites are candidates to be
regulated by SIRT5, and are predicted to have influences on
CPS1 enzymatic activity. Indeed, in the hyperglutarylated state,
we find CPS1 has reduced enzymatic activity. Future studies will
identify other proteins whose activity could be regulated by
SIRT5-mediated deglutarylation, and the proteomic data sets
in this study will be a rich resource for future discovery.
In addition to the predominant mitochondrial Kglu substrates
revealed by the proteomic analyses, we also identified at least
40 nonmitochondrial substrates, suggesting potential functions
for Kglu outside mitochondria. Of particular interest, we identi-
fied three Kglu sites on core histone H2B (H2BK5, H2BK116,
and H2BK120). Modifications on histones are critical for
chromatin-mediated processes, including regulation of gene
expression. Our previous studies identified new lysine acylation
modifications on histones (Chen et al., 2007; Tan et al., 2011;
Xie et al., 2012), including lysine crotonylation and succinylation,
revealing potential crosstalk between cellular physiology and
gene transcription.(F) Glutaryl-CoA or glutarate was incubated with heat-inactivated hepatic
mitochondrial lysates and monitored for changes in protein glutarylation using
an anti-Kglu antibody.
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diverse roles in regulating aspects of cellular physiology. Meta-
bolic pathways generating glutaryl-CoA are different from those
generating succinyl-CoA and malonyl-CoA (Figure 1A). For
example, glutaryl-CoA is an important intermediate in lysine and
tryptophan metabolism, whereas succinyl-CoA participates in
the TCA cycle and metabolism of branched-chain amino acids
and odd-numbered fatty acids, and malonyl-CoA participates in
fatty acid andpolyketide biosynthesis. Thus, these differentmod-
ifications are positioned to regulate differentmetabolic pathways.
Furthermore, glutarylation could be relevant in some disease
states, such as glutaric acidemia. The GCDHKO mouse model
of this diseasehashigh levels of protein glutarylation,whichcould
reduce the activity of important metabolic enzymes. Importantly,
these findings also show that one alternate fate of unoxidized glu-
taryl-CoA in this disease is protein glutarylation, which could be
either nonenzymaticly or enzymatically catalyzed. It is tempting
to speculate that these findings are broadly applicable to other
diseases associated with mutations in acyl-CoA dehydroge-
nases and could lead to subsequent protein acylation.
While increases in acetylation were previously associated with
reduced sirtuin activity, we are now beginning to appreciate the
complexity of identifying themolecular events leading to changes
in acylation. In this study, for example, we find that reduction or
ablation of the deacylase SIRT5 leads to increases in protein glu-
tarylation; we also find that ablation of a protein that handles
glutaryl-CoA (GCDH) leads to increases in protein glutarylation.
Thus, future studies will need to consider the fate and/or flux of
an acyl-CoA in contributing to the protein acylation balance.
Multiple chemical and biological differences exist among
lysine acetylation, succinylation, and glutarylation. The nega-
tively charged nature of lysine succinylation and glutarylation
has the potential to induce significant structural changes on
target proteins. Furthermore, it is possible that Kglu could have
distinct regulatory role different from lysine succinylation or
malonylation based on the larger size of the modification. Future
studieswill be focusedonunderstanding the full regulatory scope
of protein glutarylation and the interplay between thesemodifica-
tions in the rapidly expanding landscape of protein acylation.
EXPERIMENTAL PROCEDURES
Western Blotting Analysis
Protein extracts were resolved by SDS-PAGE, transferred to polyvinylidene
difluoride or nitrocellulose membrane, and probed with pan-anti-acyl-lysine
modification or protein sequence specific antibodies. See Supplemental
Experimental Procedures for details.
Immunoprecipitation of Kglu Peptides
ThepHof the tryptic peptide solutionwas adjusted to pH8.0 by adding 100mM
NH4HCO3 buffer (pH 8.0) and then incubated with the anti-Kglu antibody (PTM
Biolabs, Inc) immobilized with protein A agarose beads at room temperature
with gentle shaking.After 4 hr of incubation, thebeadswerewashed three times
with precold NETN buffer (50 mM Tris-Cl [pH 8.0], 100 mM NaCl, 1 mM EDTA,
0.5% NP-40), twice with ETN buffer (50 mM Tris-Cl [pH 8.0], 100 mM NaCl,
1 mM EDTA), and once with cold water. The enriched peptides were eluted
from the beads by washing with 0.1% TFA three times.
HPLC-MS/MS and MS Data Analysis
Enriched Kglu peptides were anaylzed by reverse-phase HPLC/MS/MS anal-
ysis by an Eksigent NanoLC-1D plus HPLC system (AB SCIEX) connected
to an LTQ Velos Orbitrap mass spectrometer (Thermo Fisher Scientific). MS/CMS data were analyzed by Mascot software (version 2.1) and MaxQuant
software (version 1.0.13.13). All the data were searched against either NCBI
RefSeq E. coli k12 protein database (4,123 sequences), IPI human protein
database (v3.70, 87,069 sequences), or IPI mouse protein database (v3.74,
56,860 sequences). See Supplemental Experimental Procedures for details.
In Vitro Deglutarylation Assays
Reactions were performed in a final volume of 50 ml per well in a 96-well micro-
plate for fluorometric assays and in a final volume of 10 ml for peptides assays
as previously described (Peng et al., 2011). See Supplemental Experimental
Procedures for details.
32P-NAD+ Consumption Assay
Based on the method described by Du et al. (2011), reactions were performed
in a total volume of 10 ml in 50mMTris-HCl (pH 9.0), 4 mMMgCl2, 50mMNaCl,
0.5 mM DTT, and 0.5 mCi 32P-NAD+ (PerkinElmer, NEG023X, 800 Ci/mmol) in
the presence of either 2 mg acylated-BSA or 1 mg acylated-H4 peptide sub-
strate. See Supplemental Experimental Procedures for details.
CPS1-FLAG Immunoprecipitation
Transfected HEK293T cells were washed with PBS and scraped into NP-40
lysis buffer (25 mM Tris HCL [pH 7.5], 50 mM NaCl, 1% NP-40, 2 mM EDTA,
and cocktail of protease inhibitors). After 15 min on ice, the cells were homog-
enized in chilled racks with a TissueLyser bead mill (Invitrogen) for 2 min at
30 Hz. Lysates were centrifuged at 14,000 3 g, 20 min, and the supernatants
were incubated with FLAG M2 antibody resin (Sigma-Aldrich) overnight at
4 C. The FLAG resin was washed three times with lysis buffer and once
with TBS, and the CPS1-FLAG protein was elutedwith 300 ng/ml FLAG peptide
(Sigma-Aldrich).
CPS1 Activity Assay
CPS1 activity was assessed by measuring converted citrulline by a colori-
metric method with modification (Chan et al., 2009; Pierson, 1980). See Sup-
plemental Experimental Procedures for details.
In Vitro Deglutarylation of CPS1 by SIRT5
Glutarylated and unglutarylated CPS1 were incubated with SIRT5 or the cata-
lytically inactive SIRT5HY mutant in 13 SDAC Buffer (50 mM Tris-HCl [pH 9],
4 mMMgCl2, 50mMNaCl, 0.5mMDTT, 1mMNAD
+) for 1 hr at 37C. Reaction
was stopped by adding SDS sample buffer or by freezing at 20C.
Animal Experiments
Animal studies were performed according to protocols approved by the Uni-
versity of Michigan or Duke University. See Supplemental Experimental Proce-
dures for details.
See Supplemental Experimental Procedures for other experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, five tables, and Supple-
mental Experimental Procedures and can be found with this article at http://
dx.doi.org/10.1016/j.cmet.2014.03.014.
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